Thursday, March 27, 2025
spot_img

ZetaDisplay announces expiration date for tender offer

ZetaDisplay announces expiration date for tender offer

21 March 2025

On 14 March 2025, ZetaDisplay AB (publ) (the “Company”) announced that in conjunction with an intended issue of new SEK denominated senior secured bonds (the “New Bonds”), it was offering holders of the Company’s existing senior secured bonds with ISIN SE0018742488 (the ”Existing Bonds”) to tender any and all of their Existing Bonds for purchase by the Company for cash at a price of 102.325% plus accrued but unpaid interest subject to the terms and conditions set forth in the tender information document dated 14 March 2025 (the “Tender Information Document“) (the “Tender Offer”).

In accordance with the Tender Information Document, the Company hereby announces that the Tender Offer will expire on 21 March 2025, being today and in connection with the close of the book building process for the New Bonds. The settlement of the Tender Offer is expected to occur on 4 April 2025. The Tender Offer remains subject to the successful issuance of New Bonds and the terms and conditions described in the Tender Information Document.

Dealer Managers:
Nordea: [email protected]
Pareto Securities: [email protected]

For further information please contact:

Anders Olin, President & CEO

Mobile: +46 076-101 14 88

E-Mail: [email protected]

Claes Pedersen, CFO

Mobile: +45 23-68 86 58

E-Mail: [email protected]

Powered by SlickText.com

Hot this week

Atmus Filtration’s Path To Growth: Analyst Highlights Strong Financials, Tariff Pricing Power

Atmus Filtration Technologies Inc. ATMU has strong growth potential,...

Soleno Shares Are Up Today: What’s Going On?

Soleno Therapeutics, Inc. SLNO shares are trading higher Thursday...

Ultragenyx Stays On JPMorgan’s Focus List As Analyst Highlights Strong Long-Term Positioning

JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s...

Candel Therapeutics Shares Are Down Today: What’s Going On?

Candel Therapeutics, Inc. CADL shares are are trading lower...

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

The Japanese Ministry of Health, Labour and Welfare on...

Topics

Atmus Filtration’s Path To Growth: Analyst Highlights Strong Financials, Tariff Pricing Power

Atmus Filtration Technologies Inc. ATMU has strong growth potential,...

Soleno Shares Are Up Today: What’s Going On?

Soleno Therapeutics, Inc. SLNO shares are trading higher Thursday...

Ultragenyx Stays On JPMorgan’s Focus List As Analyst Highlights Strong Long-Term Positioning

JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s...

Candel Therapeutics Shares Are Down Today: What’s Going On?

Candel Therapeutics, Inc. CADL shares are are trading lower...

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

The Japanese Ministry of Health, Labour and Welfare on...

Chemomab Therapeutics’ Touts Positive Data From Experimental Drug For Chronic Liver Disease

Chemomab Therapeutics Ltd. CMMB on Thursday released results from the...

Vertical Aerospace Unfairly Undervalued, Says Bullish Analyst

D. Boral Capital analyst Jesse Sobelson initiated coverage on...

Petrus Resources Announces Monthly Activity Update

CALGARY, Alberta, March 27, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img